-
), a consortium including AstraZeneca, TU Eindhoven, University of Gothenburg, Chalmers, and FinnAdvance. Nanoparticle drug delivery is a high-dimensional, multi-objective design problem: formulations
-
transport proteins in lipid membranes. Furthermore, the ultimate long-term goal is to integrate these cells in a dialysis machines. The objectives for this position are to: Formulate synthetic cells with
Searches related to protein formulation
Enter an email to receive alerts for protein-formulation positions